Global (United States, European Union and China) Preimplantation Genetics Diagnosis (PGD) Market Research Report 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gender Selection
  • 1.4.3 Chromosomal Abnormalities
  • 1.4.4 Single Gene Disorders
  • 1.4.5 HLA Typing
  • 1.4.6 Aneuploidy
  • 1.4.7 X-Linked Diseases
  • 1.4.8 Other
• 1.5 Market by Application
  • 1.5.1 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Preimplantation Genetics Diagnosis (PGD) Market Perspective (2015-2026)
• 2.2 Preimplantation Genetics Diagnosis (PGD) Growth Trends by Regions
  • 2.2.1 Preimplantation Genetics Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Preimplantation Genetics Diagnosis (PGD) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Preimplantation Genetics Diagnosis (PGD) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Market Size
  • 3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2015-2020)
  • 3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
  • 3.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2019
• 3.3 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
• 3.4 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
• 3.5 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2015-2020)
• 4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2021-2026)

5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application (2015-2026)

• 5.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
• 5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 6.2 Preimplantation Genetics Diagnosis (PGD) Key Players in North America (2019-2020)
• 6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 7.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Europe (2019-2020)
• 7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

8 China

• 8.1 China Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 8.2 Preimplantation Genetics Diagnosis (PGD) Key Players in China (2019-2020)
• 8.3 China Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 8.4 China Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 9.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Japan (2019-2020)
• 9.3 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 9.4 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 10.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

11 India

• 11.1 India Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 11.2 Preimplantation Genetics Diagnosis (PGD) Key Players in India (2019-2020)
• 11.3 India Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 11.4 India Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
• 12.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
• 12.4 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Natera, Inc
  • 13.2.1 Natera, Inc Company Details
  • 13.2.2 Natera, Inc Business Overview and Its Total Revenue
  • 13.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.2.5 Natera, Inc Recent Development
• 13.3 PerkinElmer
  • 13.3.1 PerkinElmer Company Details
  • 13.3.2 PerkinElmer Business Overview and Its Total Revenue
  • 13.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.3.5 PerkinElmer Recent Development
• 13.4 Illumina
  • 13.4.1 Illumina Company Details
  • 13.4.2 Illumina Business Overview and Its Total Revenue
  • 13.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.4.5 Illumina Recent Development
• 13.5 F. Hoffmann-La Roche
  • 13.5.1 F. Hoffmann-La Roche Company Details
  • 13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  • 13.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.5.5 F. Hoffmann-La Roche Recent Development
• 13.6 Thermo Fisher Scientific
  • 13.6.1 Thermo Fisher Scientific Company Details
  • 13.6.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.6.5 Thermo Fisher Scientific Recent Development
• 13.7 Laboratory Corporation of America Holdings
  • 13.7.1 Laboratory Corporation of America Holdings Company Details
  • 13.7.2 Laboratory Corporation of America Holdings Business Overview and Its Total Revenue
  • 13.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.7.5 Laboratory Corporation of America Holdings Recent Development
• 13.8 Agilent Technologies
  • 13.8.1 Agilent Technologies Company Details
  • 13.8.2 Agilent Technologies Business Overview and Its Total Revenue
  • 13.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.8.5 Agilent Technologies Recent Development
• 13.9 Quest Diagnostics Incorporated
  • 13.9.1 Quest Diagnostics Incorporated Company Details
  • 13.9.2 Quest Diagnostics Incorporated Business Overview and Its Total Revenue
  • 13.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.9.5 Quest Diagnostics Incorporated Recent Development
• 13.10 Cooper Surgical
  • 13.10.1 Cooper Surgical Company Details
  • 13.10.2 Cooper Surgical Business Overview and Its Total Revenue
  • 13.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
  • 13.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 13.10.5 Cooper Surgical Recent Development
• 13.11 Beijing Genomics Institute (BGI)
  • 10.11.1 Beijing Genomics Institute (BGI) Company Details
  • 10.11.2 Beijing Genomics Institute (BGI) Business Overview and Its Total Revenue
  • 10.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
  • 10.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 10.11.5 Beijing Genomics Institute (BGI) Recent Development
• 13.12 Genea Limited
  • 10.12.1 Genea Limited Company Details
  • 10.12.2 Genea Limited Business Overview and Its Total Revenue
  • 10.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
  • 10.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
  • 10.12.5 Genea Limited Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer